Table 3.
Anti COVID-19 Vaccination | |||||
---|---|---|---|---|---|
Therapies | None | 1 Dose | 2+ Doses | p-Value * | Total |
N = 743 | N = 62 | N = 151 | N = 956 | ||
Monoclonal antibodies, n(%) | 30 (4.0%) | 4 (6.5%) | 38 (25.2%) | <0.001 | 72 (7.5%) |
Heparin, n(%) | 579 (77.9%) | 45 (72.6%) | 110 (72.8%) | 0.291 | 734 (76.8%) |
Remdesivir, n(%) | 186 (25.1%) | 18 (29.0%) | 5 (3.3%) | <0.001 | 209 (21.9%) |
Glucocorticoids, n(%) | 586 (78.9%) | 44 (71.0%) | 112 (74.2%) | 0.194 | 742 (77.6%) |
Immunomodulants, n(%) | 50 (6.7%) | 4 (6.5%) | 2 (1.3%) | 0.035 | 56 (5.9%) |
* Chi-square test.